Article
Oncology
Nathalie Blad, Richard Palmqvist, Pontus Karling
Summary: This study found that tumor stage and tumor localization are associated with the extent of fecal calprotectin (FC) levels in patients with colorectal cancer (CRC). Patients with right-sided tumors and higher tumor stages were more likely to have elevated FC levels.
Article
Orthopedics
Jisi Xing, Jiahao Li, Zijian Yan, Yijin Li, Xiaofang Liu, Lilei He, Ting Xu, Changbing Wang, Lilian Zhao, Ke Jie
Summary: This study aimed to investigate the accuracy and sensitivity of calprotectin (CLP) in the diagnosis of periprosthetic joint infection (PJI). The results showed that CLP can be a reliable biomarker and may be used as a diagnostic criterion for PJI in the future.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH
(2022)
Review
Oncology
Geertje B. Liemburg, Daan Brandenbarg, Marjolein Y. Berger, Saskia F. A. Duijts, Gea A. Holtman, Geertruida H. de Bock, Joke C. Korevaar, Annette J. Berendsen
Summary: This study aimed to evaluate the diagnostic accuracy of commonly used screeners in CRC follow-up in primary care. The findings showed a sensitivity of 59% and specificity of 89% for CEA screening, while limited data was available for ultrasound and clinical examination. In practice, GPs could perform CEA screening, while radiological examination should remain in a hospital setting.
EUROPEAN JOURNAL OF CANCER CARE
(2021)
Article
Gastroenterology & Hepatology
Noel Pin-Vieito, Laura Garcia Nimo, Luis Bujanda, Begona Roman Alonso, Maria Angeles Gutierrez-Stampa, Vanessa Aguilar-Gama, Isabel Portillo, Joaquin Cubiella
Summary: Optimizing colonoscopy resources in primary health care is challenging. This study assessed the impact of different FIT positivity thresholds on CRC detection in primary care, suggesting that a tailored FIT threshold should be based on colonoscopy capacity and CRC prevalence in specific populations.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
(2021)
Article
Medicine, Research & Experimental
Natalia Calanzani, Aina Chang, Marije Van Melle, Merel M. Pannebakker, Garth Funston, Fiona M. Walter
Summary: Primary care professionals play a crucial role in both preventing and detecting colorectal cancer, assessing patients presenting with potential symptoms, and utilizing various testing options for evaluation.
ADVANCES IN THERAPY
(2021)
Article
Multidisciplinary Sciences
Melike Kurt, Zeki Yumuk
Summary: The study aimed to evaluate the use of antibodies against Fusobacterium nucleatum in the diagnosis of colorectal cancer (CRC), finding that IgA and IgG antibodies were significantly higher in CRC patients compared to healthy controls, but the discriminative ability of the ELISA test was not adequate to be considered as a diagnostic tool.
SCIENTIFIC REPORTS
(2021)
Article
Pediatrics
Rebecca McNally Keehn, Nancy Swigonski, Brett Enneking, Tybytha Ryan, Patrick Monahan, Ann Marie Martin, Lisa Hamrick, Girija Kadlaskar, Angela Paxton, Mary Ciccarelli, Brandon Keehn
Summary: The study evaluated the diagnostic accuracy of the Early Autism Evaluation (EAE) Hub system, which provides training and support to primary care providers in diagnosing young children at risk for autism spectrum disorder (ASD). The results showed that trained primary care providers can make accurate ASD diagnoses in most cases.
Article
Gastroenterology & Hepatology
Toer W. Stevens, Krisztina Gecse, Jerrold R. Turner, Gert de Hertogh, David T. Rubin, Geert R. D'Haens
Summary: A post hoc analysis of data from a phase 4 trial found that FC concentration can be used to discriminate patients with ongoing microscopic inflammation from patients with histologic remission even in patients with complete endoscopic healing of UC. The optimal cut-off concentration of FC is between 75 and 100 μg/g.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Review
Medicine, General & Internal
Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang, Hua-Guo Xu
Summary: Fecal calprotectin (FC) levels are correlated with the disease activity of inflammatory bowel diseases (IBD), but its usefulness in predicting IBD relapse is yet to be determined. This study aimed to evaluate the efficacy of FC in predicting IBD relapse. A total of 24 prospective studies were included in the meta-analysis, and the optimal FC cut-off value was found to be 152 μg/g. The pooled sensitivity and specificity of FC were 0.720 (0.528 to 0.856) and 0.740 (0.618 to 0.834), respectively. FC is a valuable non-invasive and cost-effective biomarker for early prediction of IBD relapse, with an ideal threshold of 152 μg/g.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Medicine, General & Internal
Julie McLellan, Carl Heneghan, Nia Roberts, Annette Pluddemann
Summary: This systematic review and meta-analysis found limited evidence supporting the diagnostic accuracy of self-diagnosis compared with clinical diagnosis for common conditions in primary care. The studies included in the review mainly focused on vaginal infection, common skin conditions, and HIV. The overall findings suggest that routine self-diagnosis for these conditions is not supported in primary care.
Article
Medicine, General & Internal
Farzana Rahman, Mihir Trivedy, Christopher Rao, Funmi Akinlade, Ahmer Mansuri, Atul Aggarwal, Faidon-Marios Laskaratos, Nirooshun Rajendran, Saswata Banerjee
Summary: This study investigated the diagnostic performance of FIT in symptomatic patients, analyzing the proportion of FIT-negative colorectal cancers (CRC) missed and how to mitigate this risk. The results showed that FIT had comparable performance with the existing literature in detecting CRC, but there was a certain proportion of FIT-negative CRC. Therefore, relying solely on FIT to determine referrals to secondary care or further investigations needs caution.
Review
Biochemistry & Molecular Biology
Aneta L. Zygulska, Piotr Pierzchalski
Summary: Colorectal cancer is a leading cause of cancer death worldwide, and early diagnosis is crucial for improving survival rates. Current diagnostic methods have suboptimal accuracy, while new molecular noninvasive tests based on CRC alterations are more sensitive and specific. Identifying ideal diagnostic biomarkers remains a challenge.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Medicine, General & Internal
Gonzalo Hijos-Mallada, Raul Velamazan, Raul Marti, Eduardo Chueca, Samantha Arechavaleta, Alberto Lue, Fernando Gomollon, Angel Lanas, Carlos Sostres
Summary: The study found that using a four-biomarker point-of-care test could effectively monitor the inflammatory activity in IBD patients, with fecal calprotectin showing the best sensitivity. Patients with negative results in all four biomarkers had a 100% negative predictive value, while those with all four biomarkers positive had a 100% positive predictive value of endoscopic inflammatory activity.
Article
Medicine, General & Internal
Willemijn de Klaver, Pieter H. A. Wisse, Francine van Wifferen, Linda J. W. Bosch, Connie R. Jimenez, Rene W. M. van der Hulst, Remond J. A. Fijneman, Ernst J. Kuipers, Marjolein J. E. Greuter, Beatriz Carvalho, Manon C. W. Spaander, Evelien Dekker, Veerle M. H. Coupe, Meike de Wit, Gerrit A. Meijer
Summary: In this study, the multitarget FIT (mtFIT) showed improved diagnostic accuracy in detecting advanced neoplasia compared to FIT, particularly in detecting advanced adenomas. Early health technology assessment indicated that mtFIT-based screening could be cost-effective.
ANNALS OF INTERNAL MEDICINE
(2021)
Article
Oncology
Andrea Cruz, Carla M. Carvalho, Alexandra Cunha, Anais Crespo, Agueda Iglesias, Laura Garcia-Nimo, Paulo P. Freitas, Joaquin Cubiella
Summary: The study aimed to analyze the diagnostic value of six biomarkers in stool samples of patients with CRC, advanced adenomas, other lesions, and healthy individuals. Results showed that Hb and M2-PK levels were increased in CRC patients compared to controls, suggesting a potential as fecal diagnostic biomarkers for CRC detection.
Article
Health Care Sciences & Services
Hayden Holmes, Jessica McMaster, Heather Davies, Victoria Vaines, James Turvill
Summary: This study analyzed the data from the York Fecal Calprotectin Care Pathway (YFCCP) and found that it is a cost-effective and beneficial approach for treating patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) compared to the current recommended pathways.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
(2022)
Article
Oncology
Stacey Jones, Brian Hogan, Kirtida Patel, Shiwei Ooi, Philip Turton, Rajgopal Achuthan, Baek Kim
Summary: The study found that the uptake of chemoprevention is low in breast cancer patients with high family history risk. The main motivating factors for accepting chemoprevention were breast cancer prevention, belief in its effectiveness, and personal perception of breast cancer risk. On the other hand, the main barriers for refusal included concerns about side effects and lack of information.
BREAST CANCER RESEARCH AND TREATMENT
(2021)
Article
Oncology
Rajiv V. Dave, Baek Kim, Alona Courtney, Rachel O'Connell, Tim Rattay, Vicky P. Taxiarchi, Jamie J. Kirkham, Elizabeth M. Camacho, Patricia Fairbrother, Nisha Sharma, Christopher W. J. Cartlidge, Kieran Horgan, Stuart A. McIntosh, Daniel R. Leff, Raghavan Vidya, Shelley Potter, Chris Holcombe, Ellen Copson, Charlotte E. Coles, Ramsey I. Cutress, Ashu Gandhi, Cliona C. Kirwan
Summary: The majority of 'COVID-altered' management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown.
BRITISH JOURNAL OF CANCER
(2021)
Article
Primary Health Care
James L. Turvill, Daniel Turnock, Dan Cottingham, Monica Haritakis, Laura Jeffery, Annabelle Girdwood, Tom Hearfield, Alex Mitchell, Ada Keding
Summary: The study aimed to assess the diagnostic accuracy of FIT in patients suspected of CRC, revealing that FIT can effectively identify CRC and significant premalignant polyps, as well as other organic enteric diseases, potentially facilitating more personalized risk assessment for colorectal cancer.
BRITISH JOURNAL OF GENERAL PRACTICE
(2021)
Article
Biochemistry & Molecular Biology
Samantha A. Hutchinson, Alex Websdale, Giorgia Cioccoloni, Hanne Roberg-Larsen, Priscilia Lianto, Baek Kim, Ailsa Rose, Chrysa Soteriou, Arindam Pramanik, Laura M. Wastall, Bethany J. Williams, Madeline A. Henn, Joy J. Chen, Liqian Ma, J. Bernadette Moore, Erik Nelson, Thomas A. Hughes, James L. Thorne
Summary: Triple negative breast cancer (TNBC) is difficult to treat due to lack of targeted therapies, with chemotherapy often failing in patients with high circulating cholesterol. The study reveals that LXR ligands can lead to chemotherapy resistance in TNBC, with LXRalpha and P-glycoprotein being markers of poor prognosis in patients with cancer recurrences. Targeting the LXRalpha:P-glycoprotein axis may offer new treatment options for TNBC patients who do not respond well to systemic chemotherapy.
Article
Oncology
Noha Gwili, Stacey J. Jones, Waleed Al Amri, Ian M. Carr, Sarah Harris, Brian Hogan, William E. Hughes, Baek Kim, Fiona E. Langlands, Rebecca A. Millican-Slater, Arindam Pramanik, James L. Thorne, Eldo T. Verghese, Geoff Wells, Mervat Hamza, Layla Younis, Nevine M. F. El Deeb, Thomas A. Hughes
Summary: This study identified the consistent transcriptome of primary BCSCs shared across breast cancer subtypes and found ITGA7 as a predictive marker for chemotherapy response, in accordance with its downregulation in BCSCs.
BRITISH JOURNAL OF CANCER
(2021)
Article
Oncology
Jenna L. Morgan, Vinton Cheng, Peter A. Barry, Ellen Copson, Ramsey Cutress, Rajiv Dave, Beatrix Elsberger, Patricia Fairbrother, Sue Hartup, Brian Hogan, Kieran Horgan, Cliona C. Kirwan, Stuart A. McIntosh, Rachel L. O'Connell, Neill Patani, Shelley Potter, Tim Rattay, Lisa Sheehan, Lynda Wyld, Baek Kim
Summary: This study aimed to understand the practices of UK breast multidisciplinary teams in managing locoregional recurrence of breast cancer and identified variations in pre-operative staging investigations, surgical management, and adjuvant therapy. Further research is needed to determine the impact of these management patterns on patient outcomes.
Article
Oncology
Subashini Chandrapalan, Farah Khasawneh, Baljit Singh, Stephen Lewis, James Turvill, Krishna Persaud, Ramesh P. Arasaradnam
Summary: There is a need to triage and prioritize patients with high-risk findings in the already strained endoscopy services in the U.K. Urinary volatile organic compounds have been found to be useful for the detection of high-risk findings.
Article
Oncology
Rajiv Dave, Beatrix Elsberger, Vicky Taxiarchi, Ashu Gandhi, Cliona Kirwan, Baek Kim, Elizabeth Camacho, Charlotte Coles, Ellen Copson, Alona Courtney, Kieran Horgan, Patricia Fairbrother, Chris Holcombe, Jamie Kirkham, Daniel Leff, Stuart B. McIntosh, Rachel O'Connell, Ricardo Pardo, Shelley Potter, Tim Rattay, Nisha Sharma, Raghavan Vidya, Ramsey Cutress
Summary: The B-MaP-C study examined changes in breast cancer care during the COVID-19 pandemic. It found that bridging endocrine therapy (BrET) is safe and effective in reducing tumor size and improving prognosis during the waiting period for surgery.
BREAST CANCER RESEARCH AND TREATMENT
(2023)
Article
Surgery
Stacey Jones, Rajgopal Achuthan, Shiwei Ooi, Baek Kim
Summary: An audit was conducted on patients undergoing elective breast surgery, revealing a high number of inappropriate preoperative blood tests and prompting education and development of guidelines. A re-audit showed a significant reduction in the number of blood tests requested, resulting in a 71% reduction in financial expenditure.
JOURNAL OF PERIOPERATIVE PRACTICE
(2021)
Article
Surgery
Alona Courtney, Rachel O'Connell, Tim Rattay, Baek Kim, Ramsey I. Cutress, Cliona C. Kirwan, Ashu Gandhi, Patricia Fairbrother, Nisha Sharma, Christopher W. J. Cartlidge, Kieran Horgan, Stuart A. McIntosh, Daniel R. Leff, Raghavan Vidya, Shelley Potter, Chris Holcombe, Ellen Copson, Charlotte E. Coles, Rajiv V. Dave
INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS
(2020)
Letter
Gastroenterology & Hepatology
James Turvill
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
(2020)
Letter
Gastroenterology & Hepatology
Charlotte Chuter, Ada Keding, Hayden Holmes, Daniel Turnock, James Turvill
FRONTLINE GASTROENTEROLOGY
(2020)
Article
Medicine, General & Internal
Emma G. MacInnes, Jenny Piper, Catherine Tait, Alison Waterworth, Raj Achuthan, Brian Hogan, Shireen McKenzie, Philip Turton, Baek Kim, Kieran Horgan
CUREUS JOURNAL OF MEDICAL SCIENCE
(2020)
Article
Gastroenterology & Hepatology
James Turvill, Daniel Turnock
FRONTLINE GASTROENTEROLOGY
(2020)